While oral antidiabetics and lipid-lowering agents offer potential therapeutic benefits for vitiligo by modulating oxidative stress and inflammation, their use presents limitations ( In conclusion, drug repurposing appears to be an interesting option for vitiligo patients, especially with regards to therapies already approved and prescribed for metabolic disturbances
Longer term, Novos expanding pipeline , including late-stage GLP-1 trials targeting Alzheimers and other metabolic disorders, provides asymmetric upside , where success could be transformative but failure carries limited structural downside
Stokes, E., Shuang, T., Zhang, Y., Pei, Y., Fu, M., Guo, B
Product must be refrigerated
Yes, GLP-1 has been shown to play an important role in metabolic homeostasis and healthy weight regulation